Sarah Danielle Slack

Sarah Danielle Slack

Auto-generated profile, based on publicly available information

Sarah Danielle Slack

Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
SCShijie Cao
Shijie Cao
SSSarah D. Slack
Sarah D. Slack
CLClaire Levy
Claire Levy
SHSean M. Hughes
Sean M. Hughes
YJYonghou Jiang
Yonghou Jiang
KWKim A. Woodrow
Kim A. Woodrow
Targeted nanocarriers deliver HIV-1 latency-reversing agents to CD4 + T cells in the lymph nodes.

20 July 2023 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
FCFelipe Santos de Carvalho
Felipe Santos de Carvalho
SSSarah Danielle Slack
Sarah Danielle Slack
FBFrancisco Barbosa-Júnior
Francisco Barbosa-Júnior
MCMateus Rennó de Campos
Mateus Rennó de Campos
GCGuilherme Silveira Castro
Guilherme Silveira Castro
FBFernando Bellissimo-Rodrigues
Fernando Bellissimo-Rodrigues
This work aimed to study the role of different SARS-CoV-2 lineages in the epidemiology of multiple waves of the COVID-19 pandemic in Ribeirão Preto (São Paulo state), with comparison within Brazil and globally. Viral genomic sequencing was combined with clinical and sociodemographic information of 2,379 subjects at a large Brazilian hospital. On the whole 2,395 complete SARS-CoV-2 genomes were obtained from April 2020 to January 2022. We report variants of concern (VOC) and interest (VOI) dynamics and the role of Brazilian lineages. We identified three World Health Organization VOCs (Gamma, Delta, Omicron) and one VOI (Zeta), which caused distinct waves in this cohort. We also identified 47 distinct Pango lineages. Consistent with the high prevalence of Gamma in Brazil, Pango lineage P.1 dominated infections in this cohort for half of 2021. Each wave of infection largely consisted of a single variant group, with each new group quickly and completely rising to dominance. Despite increasing vaccination in Brazil starting in 2021, this pattern was observed throughout the study and is consistent with the hypothesis that herd immunity tends to be SARS-CoV-2 variant-specific and does not broadly protect against COVID-19.

27 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KHKirk R. Hohsfield
Kirk R. Hohsfield
PCPatrick Carry
Patrick Carry
SSSarah D. Slack
Sarah D. Slack
CRCharlie T. Repaci
Charlie T. Repaci
LVLauren A. Vanderlinden
Lauren A. Vanderlinden
RJRandi Johnson
Randi Johnson
Seroconversion (SV) marks the initiation of islet autoimmunity (IA) and pre-clinical phase of type 1 diabetes (T1D), yet the contributions of immune cells beyond cytotoxic T cells remain unclear. We applied high-resolution immune cell-type deconvolution using peripheral blood DNA methylation data from nested case-control samples of the Diabetes Autoimmunity Study in the Young (DAISY; n=151) and The Environmental Determinants of Diabetes in the Young (TEDDY; n=166) to estimate immune cell proportions before SV (pre-SV) and after SV (SV) and construct functional ratios, such as the neutrophil-to-lymphocyte ratio (NLR). Using linear models, we evaluated differences between T1D cases and controls at pre-SV, SV, and the change across timepoints. Pre-SV, T1D cases had higher NLR and lower CD4T/CD8T cell ratios. At SV, the combined B-CD4T-CD8T memory/naïve ratio was reduced in cases. From pre-SV to SV, T1D cases also showed attenuated increases in NLR, B-memory/naïve, and B– CD4T–CD8T memory/naïve ratios. These patterns may reflect delayed or disrupted immune maturation, with persistence of naïve cells or impaired transition to memory subsets following antigen exposure. Our findings suggest that changes in innate and adaptive immune dynamics emerge early in the disease process, and that peripheral immune cell ratios may serve as informative biomarkers for risk stratification and mechanistic insight for development of T1D. Article Highlights Why did we undertake this study? We undertook this study to examine immune cell profiles around a critical time window of IA seroconversion for children at an increased risk of developing T1D. What is the specific question(s) we wanted to answer? We wanted to answer questions regarding immune cell ratio differences between T1D cases and controls in three specific instances: i) pre-SV, ii) SV, and iii) the change pre-SV to SV. What did we find? We found differences in immune cell ratios between T1D cases and controls before, during, and between IA periods, which have potential etiological and pathophysiological implications. What are the implications of our findings? Our findings highlight the complexity of immunodynamics around the time of IA seroconversion and the potential for immune cell ratios to aid in T1D risk stratification and intervention.

8 September 2025 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SSSarah D. Slack
Sarah D. Slack
EEErika Esquinca
Erika Esquinca
CAChristopher H. Arehart
Christopher H. Arehart
MBMeher Preethi Boorgula
Meher Preethi Boorgula
BSBrooke Szczesny
Brooke Szczesny
RJRandi Johnson
Randi Johnson
Genetic control of gene expression in asthma-related tissues is not well-characterized, particularly for African-ancestry populations, limiting advancement in our understanding of the increased prevalence and severity of asthma in those populations. To create novel transcriptome prediction models for asthma tissues (nasal epithelium and CD4+ T cells) and apply them in transcriptome-wide association study to discover candidate asthma genes. We developed and validated gene expression prediction databases for unstimulated CD4+ T cells and nasal epithelium using an elastic net framework. Combining these with existing prediction databases (N=51), we performed TWAS of 9,284 individuals of African-ancestry to identify tissue-specific and cross-tissue candidate genes for asthma. Novel databases for CD4+ T cells and nasal epithelial gene expression prediction contain 8,351 and 10,296 genes, respectively, including four asthma loci (SCGB1A1, MUC5AC, ZNF366, LTC4S) not predictable with existing public databases. Prediction performance was comparable to existing databases and was most accurate for populations sharing ancestry with the training set (e.g. African ancestry). From transcriptome-wide association study, we identified 17 candidate causal asthma genes (adjusted P<0.1), including genes with tissue-specific (IL33 in nasal epithelium) and cross-tissue (CCNC and FBXW7) effects. Expression of IL33, CCNC, and FBXW7 may affect asthma risk in African ancestry populations by mediating inflammatory responses. The addition of CD4+ T cell and nasal epithelium prediction databases to the public sphere will improve ancestry representation and power to detect novel gene-trait associations from transcriptome-wide association study.

8 February 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SSSarah D. Slack
Sarah D. Slack
EEErika Esquinca
Erika Esquinca
CAChristopher H. Arehart
Christopher H. Arehart
MBMeher Preethi Boorgula
Meher Preethi Boorgula
BSBrooke Szczesny
Brooke Szczesny
RJRandi Johnson
Randi Johnson
Background: Genetic control of gene expression in asthma-related tissues is not well-characterized, particularly for African-ancestry populations, limiting advancement in our understanding of the increased prevalence and severity of asthma in those populations. Objective: To create novel transcriptome prediction models for asthma tissues (nasal epithelium and CD4+ T cells) and apply them in transcriptome-wide association study (TWAS) to discover candidate asthma genes. Methods: We developed and validated gene expression prediction databases for unstimulated CD4+ T cells (CD4+T) and nasal epithelium using an elastic net framework. Combining these with existing prediction databases (N=51), we performed TWAS of 9,284 individuals of African-ancestry to identify tissue-specific and cross-tissue candidate genes for asthma. For detailed Methods, please see the Supplemental Methods. Results: Novel databases for CD4+T and nasal epithelial gene expression prediction contain 8,351 and 10,296 genes, respectively, including four asthma loci ( SCGB1A1, MUC5AC, ZNF366, LTC4S ) not predictable with existing public databases. Prediction performance was comparable to existing databases and was most accurate for populations sharing ancestry with the training set (e.g. African ancestry). From TWAS, we identified 17 candidate causal asthma genes (adjusted P <0.1), including genes with tissue-specific ( IL33 in nasal epithelium) and cross-tissue ( CCNC and FBXW7 ) effects. Conclusions: Expression of IL33, CCNC , and FBXW7 may affect asthma risk in African ancestry populations by mediating inflammatory responses. The addition of CD4+T and nasal epithelium prediction databases to the public sphere will improve ancestry representation and power to detect novel gene-trait associations from TWAS. Key Messages: From the largest African-ancestry TWAS of asthma to date (N=9,284), we identified 17 candidate causal asthma genes, including: nasal epithelial expression of IL33 , and cross-tissue expression of CCNC and FBXW7 . We provide gene expression prediction databases for CD4+ T cell and nasal epithelial tissues built in African-ancestry populations, improving ancestry representation and power to detect novel gene-trait associations from TWAS. Capsule Summary: We developed novel gene expression prediction databases (CD4+ T cells, nasal airway epithelium) representing diverse populations across the African diaspora and identified 17 candidate causal asthma genes from TWAS.

17 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
FNFestus Nyasimi
Festus Nyasimi
SSSarah Sumner
Sarah Sumner
YLYanyu Liang
Yanyu Liang
XYXianyong Yin
Xianyong Yin
YPYoson Park
Yoson Park
HIHae Kyung Im
Hae Kyung Im
Genetically regulated molecular phenotypes, such as gene expression and metabolites, are widely thought to mediate the effect of disease-relevant genetic loci identified by genome-wide association studies (GWAS); however, molecular mechanisms connecting genetic variation to disease remain poorly understood. While transcriptome-wide association studies (TWAS) have identified disease-associated genes, strategies that integrate the metabolome remain underexplored. Here, we introduce MetaboXcan, a framework for predicting plasma metabolite levels from genetic data and associating them with complex traits using GWAS summary statistics. We trained lasso regression models on plasma metabolite and genotype data from the Metabolic Syndrome in Men Study (METSIM); these models outperform existing genetic metabolite predictors and generalize well across independent cohorts. MetaboXcan leverages these models to perform four complementary association analyses: (i) gene-to-trait (TWAS), (ii) gene-to-metabolite (M-TWAS), (iii) metabolite-to-trait (MWAS), and (iv) gene-expression–based metabolite-to-trait associations (g-MWAS). The framework further organizes results into metabolic pathways and gene–metabolite interaction networks to facilitate biological interpretation. Applied to chronic kidney disease (CKD), MetaboXcan identified known disease risk genes ( PDILT/UMOD, SPATA5L1/GATM ), as well as multiple CKD-relevant metabolites (e.g., glycine, homoarginine). Our integrated multiomic analysis enables biological interpretation by revealing glycine availability–centered biochemical axes spanning oxidative stress, cellular energetics, and vascular signaling, while nominating candidate mechanisms for downstream investigation. These results validate known disease-related biology with genetic evidence and generate new hypotheses for further investigation. MetaboXcan is publicly available and broadly applicable to any GWAS phenotype.